Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2017 Filed Dec 20, 2017 21:08 UTC |
O'Neil Thomas P.Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001209191-17-066697 · doc4.xml · derivative · entry 4 O'Neil Thomas P. · CIK 0001640645 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,666 Underlying: Common Stock · 4,000 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:08 UTC |
O'Neil Thomas P.Chief Financial Officer
|
Sale12/18/2017 | 8,000 | $20.00 | $160,000.00 |
DisclosureSEC source: 0001209191-17-066697 · doc4.xml · nonDerivative · entry 3 O'Neil Thomas P. · CIK 0001640645 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:08 UTC |
O'Neil Thomas P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 4,000 | $4.21 | $16,840.00 |
DisclosureSEC source: 0001209191-17-066697 · doc4.xml · nonDerivative · entry 2 O'Neil Thomas P. · CIK 0001640645 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:08 UTC |
O'Neil Thomas P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 4,000 | $1.16 | $4,640.00 |
DisclosureSEC source: 0001209191-17-066697 · doc4.xml · nonDerivative · entry 1 O'Neil Thomas P. · CIK 0001640645 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2017 Filed Dec 21, 2017 02:13 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 875 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-17-066698 · doc4.xml · derivative · entry 3 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,475 Underlying: Common Stock · 875 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| December 18, 2017 Filed Dec 21, 2017 02:13 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 875 | $20.00 | $17,500.00 |
DisclosureSEC source: 0001209191-17-066698 · doc4.xml · nonDerivative · entry 2 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,822 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017. Read SEC document |
| December 18, 2017 Filed Dec 21, 2017 02:13 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionCommon Stock | 875 | $1.89 | $1,653.75 |
DisclosureSEC source: 0001209191-17-066698 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 20:30 UTC |
Noonberg Sarah B.Director
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $17.57 | $0.00 |
DisclosureSEC source: 0001209191-17-066553 · doc4.xml · derivative · entry 1 Noonberg Sarah B. · CIK 0001706301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2027-12-14 F1 · derivative.exercise_date: The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of December 12, 2017. Read SEC document |
| December 15, 2017 Filed Mar 15, 2018 19:26 UTC Amendment |
Noonberg Sarah B.Director
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001209191-18-019990 · doc4a.xml · derivative · entry 1 Noonberg Sarah B. · CIK 0001706301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2027-12-14 F1 · derivative.exercise_price: This amendment to the previously filed Form 4 is being filed to correct a typographical error in the exercise price of the option to purchase common stock of the Issuer held by the Reporting Person. F2 · derivative.exercise_date: The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of December 12, 2017. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 23:56 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 875 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-17-063316 · doc4.xml · derivative · entry 3 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,350 Underlying: Common Stock · 875 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 23:56 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 875 | $20.00 | $17,500.00 |
DisclosureSEC source: 0001209191-17-063316 · doc4.xml · nonDerivative · entry 2 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,822 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 23:56 UTC |
Liu David YChief Scientific Officer
|
GrantCommon Stock | 875 | $1.89 | $1,653.75 |
DisclosureSEC source: 0001209191-17-063316 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,697 Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 00:14 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-17-061002 · doc4.xml · derivative · entry 6 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,225 Underlying: Common Stock · 3,500 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 00:14 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-17-061002 · doc4.xml · derivative · entry 5 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,831 Underlying: Common Stock · 3,500 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests over a four-year period, with 1/48th of the shares subject to the option vesting on the last day of each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 00:14 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 3,500 | $16.97 | $59,380.65 |
DisclosureSEC source: 0001209191-17-061002 · doc4.xml · nonDerivative · entry 4 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,822 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 00:14 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionCommon Stock | 3,500 | $1.89 | $6,615.00 |
DisclosureSEC source: 0001209191-17-061002 · doc4.xml · nonDerivative · entry 3 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 00:14 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 3,500 | $16.97 | $59,380.65 |
DisclosureSEC source: 0001209191-17-061002 · doc4.xml · nonDerivative · entry 2 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,822 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017. Read SEC document |
| November 13, 2017 Filed Nov 16, 2017 00:14 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionCommon Stock | 3,500 | $4.21 | $14,735.00 |
DisclosureSEC source: 0001209191-17-061002 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,822 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 8, 2017. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 23:04 UTC |
Shames Richard S.Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,017 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-17-056551 · doc4.xml · derivative · entry 3 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,802 Underlying: Common Stock · 2,017 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 23:04 UTC |
Shames Richard S.Chief Medical Officer
|
SaleCommon Stock | 2,017 | $19.00 | $38,323.00 |
DisclosureSEC source: 0001209191-17-056551 · doc4.xml · nonDerivative · entry 2 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 23:04 UTC |
Shames Richard S.Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,017 | $4.21 | $8,491.57 |
DisclosureSEC source: 0001209191-17-056551 · doc4.xml · nonDerivative · entry 1 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 12, 2017 23:50 UTC |
Shames Richard S.Chief Medical Officer
|
SaleCommon Stock | 3,687 | $14.31 | $52,752.86 |
DisclosureSEC source: 0001209191-17-052501 · doc4.xml · nonDerivative · entry 1 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017. F2 · shares: Includes 1,822 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 8, 2017. F3 · price: The shares were sold at prices ranging from $14.251 to $14.3443. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:08 UTC |
Shames Richard S.Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,512 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-17-050815 · doc4.xml · derivative · entry 3 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,819 Underlying: Common Stock · 1,512 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:08 UTC |
Shames Richard S.Chief Medical Officer
|
SaleCommon Stock | 1,512 | $17.00 | $25,704.00 |
DisclosureSEC source: 0001209191-17-050815 · doc4.xml · nonDerivative · entry 2 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,865 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 23:08 UTC |
Shames Richard S.Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,512 | $4.21 | $6,365.52 |
DisclosureSEC source: 0001209191-17-050815 · doc4.xml · nonDerivative · entry 1 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,865 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2017. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 23:48 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-17-050652 · doc4.xml · derivative · entry 3 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,331 Underlying: Common Stock · 3,500 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests over a four-year period, with 1/48th of the shares subject to the option vesting on the last day of each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 23:48 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 3,500 | $15.00 | $52,500.00 |
DisclosureSEC source: 0001209191-17-050652 · doc4.xml · nonDerivative · entry 2 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 23:48 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionCommon Stock | 3,500 | $4.21 | $14,735.00 |
DisclosureSEC source: 0001209191-17-050652 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 21:55 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $1.89 | $0.00 |
DisclosureSEC source: 0001209191-17-044940 · doc4.xml · derivative · entry 3 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,725 Underlying: Common Stock · 3,500 shares Expires 2024-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 21:55 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 3,500 | $12.68 | $44,380.00 |
DisclosureSEC source: 0001209191-17-044940 · doc4.xml · nonDerivative · entry 2 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.36 to $12.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 21:55 UTC |
Liu David YChief Scientific Officer
|
Exercise / conversionCommon Stock | 3,500 | $1.89 | $6,615.00 |
DisclosureSEC source: 0001209191-17-044940 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,000 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2017. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 23:36 UTC |
Williams Lewis TDirector
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $10.84 | $0.00 |
DisclosureSEC source: 0001209191-17-040261 · doc4.xml · derivative · entry 1 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2027-06-15 F1 · derivative.exercise_date: The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of June 15, 2017. Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:31 UTC |
KHOSLA CHAITAN PHDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001209191-17-035964 · doc4.xml · derivative · entry 1 KHOSLA CHAITAN PHD · CIK 0001135139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 25, 2018, or (ii) the date of the 2018 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:27 UTC |
Grant Julie PapanekDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001209191-17-035958 · doc4.xml · derivative · entry 1 Papanek Julie · CIK 0001673237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 25, 2018, or (ii) the date of the 2018 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:35 UTC |
Shanafelt ArmenDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001209191-17-035968 · doc4.xml · derivative · entry 1 Shanafelt Armen · CIK 0001656151 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 25, 2018, or (ii) the date of the 2018 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:37 UTC |
Waddill William D.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001209191-17-035969 · doc4.xml · derivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 25, 2018, or (ii) the date of the 2018 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:33 UTC |
SELICK HAROLD EDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001209191-17-035967 · doc4.xml · derivative · entry 1 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-05-25 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 25, 2018, or (ii) the date of the 2018 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 16, 2017 Filed May 17, 2018 21:48 UTC |
Giraudo BryanDirector
|
PurchaseCommon Stock | 10,000 | $6.46 | $64,566.00 |
DisclosureSEC source: 0001209191-18-031121 · doc4.xml · nonDerivative · entry 1 Giraudo Bryan · CIK 0001740847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.43 to $6.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 09, 2017 Filed May 11, 2017 00:44 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,099 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001209191-17-031420 · doc4.xml · derivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,203 Underlying: Common Stock · 19,099 shares Expires 2025-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option shall vest on the last day of each month following the first anniversary of the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| May 09, 2017 Filed May 11, 2017 00:44 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 19,099 | $1.16 | $22,154.84 |
DisclosureSEC source: 0001209191-17-031420 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2017 Filed Apr 8, 2017 01:24 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001209191-17-026368 · doc4.xml · derivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,302 Underlying: Common Stock · 20,000 shares Expires 2025-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option shall vest on the last day of each month following the first anniversary of the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| April 06, 2017 Filed Apr 8, 2017 01:24 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 20,000 | $1.16 | $23,200.00 |
DisclosureSEC source: 0001209191-17-026368 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 23:24 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,362 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-17-020336 · doc4.xml · derivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 Underlying: Common Stock · 16,362 shares Expires 2023-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option shall vest on the last day of each month following the first anniversary of the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 23:24 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 16,362 | $0.87 | $14,234.94 |
DisclosureSEC source: 0001209191-17-020336 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2016 Filed Feb 3, 2017 16:37 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-17-007438 · doc5.xml · derivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,659 Underlying: Common Stock · 3,000 shares Expires 2023-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option shall vest on the last day of each month following the first anniversary of the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| December 22, 2016 Filed Feb 3, 2017 16:37 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 3,000 | $0.87 | $2,610.00 |
DisclosureSEC source: 0001209191-17-007438 · doc5.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2016 Filed Oct 13, 2016 20:25 UTC |
Liu David YChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $21.58 | $0.00 |
DisclosureSEC source: 0001209191-16-145800 · doc4.xml · derivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2026-10-11 F1 · derivative.exercise_date: The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016. Read SEC document |
| October 11, 2016 Filed Oct 13, 2016 20:33 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 320,000 | $0.00 Strike: $21.58 | $0.00 |
DisclosureSEC source: 0001209191-16-145810 · doc4.xml · derivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2026-10-11 F1 · derivative.exercise_date: The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016. Read SEC document |
| October 11, 2016 Filed Oct 13, 2016 16:27 UTC |
O'Neil Thomas P.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $21.58 | $0.00 |
DisclosureSEC source: 0001209191-16-145801 · doc4.xml · derivative · entry 1 O'Neil Thomas P. · CIK 0001640645 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2026-10-11 F1 · derivative.exercise_date: The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016. Read SEC document |
| October 11, 2016 Filed Oct 13, 2016 20:32 UTC |
Shames Richard S.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $21.58 | $0.00 |
DisclosureSEC source: 0001209191-16-145809 · doc4.xml · derivative · entry 1 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2026-10-11 F1 · derivative.exercise_date: The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.